The Pharma CEO Who Wants To Lower Drug Prices
The pharmaceutical industry has been put on the defensive about rising cost of prescription drugs, with some executives called to testify in Congress about price gouging. In a recent interview, Andrew Witty, the chief executive of GlaxoSmithKline, who is retiring in March, talked about prices, epidemics and other health issues. The interview has been condensed and edited.
You’ve talked very publicly about the problem of rising drug prices. Why not ignore the problem?
You’ve talked very publicly about the problem of rising drug prices. Why not ignore the problem?